RGTARGENT BIOPHARMA LIMITEDMarket sensitive

U.S. In Vivo Study Supports ArtemiC Efficacy

Date and time
Announcement type
Company Update

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV